Links to COVID-19 Coverage You Should Bookmark Now.
In an effort to make it easier for physicians and healthcare providers to keep their thumb on the pulse of the COVID-19 pandemic, we’ve created a list of essential websites that can help you monitor the news, stay informed, and assist you in making the best decisions to keep your patients, staff and the community safe.
Find out more.
 
The Questionable Role of ACE Inhibitors and Angiotensin Receptor Blockers in COVID-19.
Physicians and patients should continue treatment with their usual anti-hypertensive or diabetes management therapy, says the European Society of Cardiology (ESC). There is no evidence that ACEi or ARBs, drugs which upregulate Angiotensin Converting Enzyme (ACE), increase the risk of contracting COVID-19.
Find out more.
 
Want to Up Your Telemedicine Game? Here’s How.
Until a few weeks ago, telemedicine was primarily seen as a means to improve access to specialty care, reduce healthcare costs and boost patient engagement. And while it has certainly gained traction over the last several years, it still accounted for an extremely small number of total patient encounters, was largely seen as adjunct to traditional in-person clinical care, and restrictions by payers made reimbursements difficult. Combined, these factors largely curtailed the widespread adoption of the virtual practice model. And then came the Coronavirus.
Find out more.
 
Blood Banks Currently Experiencing Extreme Shortages as a Result of Social Distancing.
For patients in need, there’s one more way the Coronavirus pandemic may affect them –a shortage of blood.
Find out more.
 
We want to hear from you!
Did you love an article you read in Endocrinology Network? Disagree with an author’s conclusions? Want to share how you solved an issue in your practice? Then Endocrinology Network editors want to hear from you! Please send your comments to GCudaKroen@mjhlifesciences.com.